全文获取类型
收费全文 | 48096篇 |
免费 | 2322篇 |
国内免费 | 600篇 |
专业分类
耳鼻咽喉 | 134篇 |
儿科学 | 807篇 |
妇产科学 | 255篇 |
基础医学 | 2411篇 |
口腔科学 | 167篇 |
临床医学 | 2717篇 |
内科学 | 7589篇 |
皮肤病学 | 134篇 |
神经病学 | 496篇 |
特种医学 | 1389篇 |
外国民族医学 | 23篇 |
外科学 | 23238篇 |
综合类 | 2822篇 |
现状与发展 | 2篇 |
预防医学 | 610篇 |
眼科学 | 66篇 |
药学 | 1030篇 |
23篇 | |
中国医学 | 63篇 |
肿瘤学 | 7042篇 |
出版年
2023年 | 1654篇 |
2022年 | 2626篇 |
2021年 | 3154篇 |
2020年 | 2614篇 |
2019年 | 1717篇 |
2018年 | 1501篇 |
2017年 | 1304篇 |
2016年 | 1244篇 |
2015年 | 1516篇 |
2014年 | 3234篇 |
2013年 | 2717篇 |
2012年 | 2559篇 |
2011年 | 2636篇 |
2010年 | 2320篇 |
2009年 | 2191篇 |
2008年 | 1817篇 |
2007年 | 1899篇 |
2006年 | 1759篇 |
2005年 | 1520篇 |
2004年 | 1298篇 |
2003年 | 1190篇 |
2002年 | 1122篇 |
2001年 | 1005篇 |
2000年 | 893篇 |
1999年 | 879篇 |
1998年 | 436篇 |
1997年 | 289篇 |
1996年 | 255篇 |
1995年 | 212篇 |
1994年 | 185篇 |
1993年 | 166篇 |
1992年 | 421篇 |
1991年 | 430篇 |
1990年 | 437篇 |
1989年 | 330篇 |
1988年 | 269篇 |
1987年 | 156篇 |
1986年 | 69篇 |
1985年 | 93篇 |
1984年 | 74篇 |
1982年 | 64篇 |
1981年 | 52篇 |
1980年 | 56篇 |
1979年 | 48篇 |
1978年 | 72篇 |
1977年 | 48篇 |
1976年 | 62篇 |
1975年 | 44篇 |
1973年 | 70篇 |
1972年 | 41篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
61.
62.
63.
《Journal of vascular and interventional radiology : JVIR》2020,31(1):25-34
PurposeTo investigate the safety of yttrium-90 radioembolization in combination with checkpoint inhibitor immunotherapy for the treatment of hepatocellular carcinoma (HCC).Materials and MethodsThis single-center retrospective study included 26 consecutive patients with HCC who received checkpoint inhibitor immunotherapy within 90 days of radioembolization from April 2015 to May 2018. Patients had preserved liver function (Child-Pugh scores A–B7) and either advanced HCC due to macrovascular invasion or limited extrahepatic disease (21 patients) or aggressive intermediate stage HCC that resulted in earlier incorporation of systemic immunotherapy (5 patients). Clinical documentation, laboratory results, and imaging results at 1- and 3-month follow-up intervals were reviewed to assess treatment-related adverse events and treatment responses.ResultsThe median follow-up period after radioembolization was 7.8 months (95% confidence interval [CI], 5.6–11.8). There were no early (30-day) mortality or grades 3/4 hepatobiliary or immunotherapy-related toxicities. Delayed grades 3/4 hepatobiliary toxicities (1–3 months) occurred in 2 patients in the setting of HCC disease progression. One patient developed pneumonitis. The median overall survival from first immunotherapy was 17.2 months (95% CI, 10.9–23.4). The median overall survival from first radioembolization was 16.5 months (95% CI, 6.6–26.4). From first radioembolization, time to tumor progression was 5.7 months (95% CI, 4.2–7.2), and progression-free survival was 5.7 months (95% CI, 4.3–7.1).ConclusionsRadioembolization combined with checkpoint inhibitor immunotherapy in cases of HCC appears to be safe and causes limited treatment-related toxicity. Future prospective studies are needed to identify the optimal combination treatment protocols and evaluate the efficacy of combination therapy. 相似文献
64.
面对来势汹汹的新型冠状病毒肺炎(COVID-19),如何能够正确、快速诊断和筛检出确诊病例显得尤为重要,国内诸多科技工作者都在积极开展相关的诊断试验研究。本文回顾了目前正在开展的十余项诊断试验的注册信息,针对其中存在的共性问题进行了讨论,重点阐述了如何使用PICOS原则构造COVID-19诊断试验的研究问题,还对金标准的设置、受试者的代表性、样本量计算和同步、独立、盲法的测定等诊断试验的设计要点进行了详细说明。旨在为广大研究者提供开展COVID-19诊断试验的设计建议,帮助研究者在顶层设计阶段减少、避免偏倚,完成高质量的临床研究,为临床诊疗提供循证医学证据。 相似文献
65.
Maaike van Gerwen MD Naomi Alpert MS Raja Flores MD Emanuela Taioli MD PhD 《American journal of industrial medicine》2020,63(2):115-120
The association between asbestos exposure, mainly in occupational settings, and malignant mesothelioma has been well established; this has prompted several countries to establish mesothelioma epidemiologic surveillance programs often at the request of national agencies. This review compares currently existing mesothelioma registries worldwide to develop a concept model for a US real-time case capture mesothelioma registry. Five countries were identified with a mesothelioma specific registry, including Italy, France, UK, Australia, and South Korea. All, except the UK, used interviews to collect exposure data. Linkage with the national death index was available or was in future plans for all registries. The registries have limited information on treatment, quality of life, and other patient-centered outcomes such as symptoms and pain management. To thoroughly collect exposure data, “real-time” enrollment is preferable; to maximize the capture of mesothelioma cases, optimal coverage, and a simplified consent process are needed. 相似文献
66.
67.
Paul J. Devlin Brian W. McCrindle James K. Kirklin Eugene H. Blackstone William M. DeCampli Christopher A. Caldarone Ali Dodge-Khatami Pirooz Eghtesady James M. Meza Peter J. Gruber Kristine J. Guleserian Bahaaladin Alsoufi Linda M. Lambert James E. OBrien Erle H. Austin Jeffrey P. Jacobs Tara Karamlou 《The Journal of thoracic and cardiovascular surgery》2019,157(2):684-695.e8
Objective
Arch obstruction after the Norwood procedure is common and contributes to mortality. We determined the prevalence, associated factors, and practice variability of arch reintervention and assessed whether arch reintervention is associated with mortality.Methods
From 2005 to 2017, 593 neonates in the Congenital Heart Surgeons' Society Critical Left Heart Obstruction cohort underwent a Norwood procedure. Median follow-up was 3.7 years. Multivariable parametric models, including a modulated renewal analysis, were performed.Results
Of the 593 neonates, 146 (25%) underwent 218 reinterventions for arch obstruction after the Norwood procedure: catheter-based (n = 168) or surgical (n = 50) at a median age of 4.3 months (quartile 1-quartile 3, 2.6-5.7). Interdigitation of the distal aortic anastomosis was protective against arch reintervention. Development of ≥ moderate tricuspid valve regurgitation and right ventricular dysfunction at any point was associated with arch reintervention. Nonsignificant variables for arch reintervention included shunt type and preoperative aortic measurements. Surgical arch reintervention was protective against arch reintervention, but transcatheter reintervention was associated with increased reintervention. Arch reintervention was not associated with increased mortality. There was wide institutional variation in incidence of arch reintervention (range, 0-40 reinterventions per 100 years patient follow-up) and in preintervention gradient (range, 0-64 mm Hg).Conclusions
Interdigitation of the distal aortic anastomosis during the Norwood procedure decreased the risk of arch reintervention. Surgical arch reintervention is more definitive than transcatheter. Arch reintervention after the Norwood procedure is not associated with increased mortality. Serial surveillance for arch obstruction, integrated with changes in right ventricular function and tricuspid valve regurgitation, is recommended after the Norwood procedure to improve outcomes. 相似文献68.
69.
70.